Living With is a health technology company offering a pocket-friendly and simple patient management application that allows medical professionals treat and track patients remotely. The app aims to revolutionise the way doctors and hospitals access digital tools to treat patients while collecting data for medical device and pharma companies. The company owns Squeezy (a popular paid medical app in the UK) and already has five products in 17 NHS Trusts. Living With also has a contract with one of the world’s greatest medical device companies. Living With will use the proceeds to give 5 data (drug/device) and 50 access customers (clinic/doctor), become HIPAA compliant for the US and to quicken sales and marketing.
days to go:
Expired
investment:
£200,000
AgPlus has created a diagnostic platform for detecting human diseases and delivering laboratory instrument results instantly, whilst keeping in mind the business requirements and unmet requirements. The company works in collaboration with leading diagnostics companies to improve and share products quickly and globally. It aims is to become known as a leader in Point of Care diagnosis.
days to go:
Expired
investment:
£65,004
Carocell Bio is an early-stage Research and Design (R&D) company aiming to develop nanoparticle-based, novel peptide anti-inflammatories to treat atopic dermatitis/eczema (AD) and other serious inflammatory diseases. It argues that millions of people continue to be affected by debilitating skin ailments, which in turn, escalates the development of new pharmaceutical drugs. The company asserts that the anti-inflammatory therapeutics market will reach US$122.6 billion by 2025 from US$95.9 billion in 2019. The company aims to be a major contender in this market. Carocell Bio has also been awarded an Innovate UK grant of £390,874. The company is seeking £1 million in equity investment over the next 12 months to show that their compounds work in human tissue biopsies of several inflammatory diseases.
days to go:
Expired
investment:
Withheld
Twisted Mirror TV (TMTV) is a comedy streaming service dedicated to short-form content, developed for several platforms such as desktop, iOS and Android. The platform has been live since August 2019 and offers free and unlimited access to international comedy including short series, sketches and stand-up comedy. The service is at the pre-revenue stage with payment solutions and an ad-serving engine in place. TMTV has signed agreements with existing mobile providers such as Vodafone, Huawei and EE to use their network base and add incremental value to its platform's services. TMTV believes this strategy will give rapid access to millions of potential customers and grow its business.
days to go:
Expired
investment:
Withheld
Evershare.io is a platform that enables fans to own a share of an artist's music income under Income Share Agreements (ISA). An ISA is an agreement between the recipient and the donors whereby the recipient agrees to share a percentage of the income generated from their project that they have raised money for. Using blockchain technology, the company is building a new way for artists and fans to engage and share the journey to musical success. For just £12 a year, an artist or band can submit their music to Evershare upon which the customer service team will help the artists or band to release their music tracks across major streaming companies such as Apple Music, Spotify, and Deezer. The artists also get to keep 100% of royalties they earn from the release of their albums or singles. They will use the investment to support and bring talent that is less heard or unknown to fans and break the unhealthy oligopoly that exists in the music publishing industry.
days to go:
Expired
investment:
Withheld
INSPHERE uses image sensors and Artificial Intelligence (AI) to guide and correct robot positioning during the manufacturing process, ensuring right-first-time production. The company argues that industrial robots are not completely accurate and can experience unplanned downtime that can cost up to £10,000 per minute. INSPHERE asserts that its solution allows factory operators to operate safely with less downtime, and with multiple robot and human operators. The company has developed three products since 2013 which have received recognition in the aerospace and industrial automation sectors. INSPHERE is now launching IONA, a network of sensors that can be permanently deployed in a manufacturing environment to monitor and control industrial robots. IONA, the company points out, uses both hardware and software to correct errors taking into account the robot and its relationship to the workpiece. INSPHERE will use the investment to diversify the reach of IONA across markets.
days to go:
Expired
investment:
£1,149,999
The world's first automated suturing tools for safe closure of standard and endoscopic wounds. Sutrue have already patented their devices and use industry-standard needles to offer clinical quality with improved speed and accuracy at the touch of a button. Needles are held in disposable cartridges as a safety feature to prevent injury when piercing skin with contaminated needles. This protects staff both during and after surgery for those working in medical and veterinary environments.
Sutrue is raising finance for the production process of their equipment, as well as applying for CE regulation via medical evaluations to receive approval to deploy their products in human and animal surgeries.
days to go:
Expired
investment:
Withheld
DMD has made its digital content distribution enterprise in the last two years. Along with that, it has developed a global cinema TVOD (Transactional Video On Demand product). The company has built a long-term distribution partnership with OTT companies, telephone/IPTV and major cable that lead the wealthiest portion of the Pay TV market, providing service to 17 million two-way homes in 19 nations in Latin America. DMD's revenue has increased by 93% YoY 2017-2018, which will help the company in reaching EBITDA breakeven in Q3 of 2019. DMD has established relationships with distributors and leading sales agents in Europe and the USA. With the proceeds, the company will acquire bigger commercial films, increase its global footprint by launching the company in Asia, Africa, and Europe, and supplement its current output with classic titles.
days to go:
Expired
investment:
£145,000
MedicSpot is a healthcare company that is aiming to revolutionise healthcare delivery by combining the advantages of online and offline care. The company provides patients at designated hospitals with diagnostic tools like a stethoscope, oximeter, blood pressure monitor and thermometer which, in turn, is connected to the MedicSpot network. Onboard General Physicians (GPs) engage in live sessions with patients, guide them on how to use the tools, and perform a variety of diagnoses like listening to a patient’s heart and lungs, looking down their throat and into their ears, taking their blood pressure and oxygen readings, and measuring their body temperature. The company is also expanding into another subsidiary, Arc Health, which it claims will perform the aforementioned tasks with more efficiency and accuracy. The company will use the investment to increase the number of Medicspot clinics to 1,000, gain further NHS market share, launch a corporate business model and allow international pilots to take place.
days to go:
Expired
investment:
£1,048,396
HighCandi is a drone services business that specialises in providing operational support to large companies, for example, in telecommunications and renewable energy sectors. It brings together independent drone service providers under one brand and uses these drones to inspect infrastructure, providing photo analysis, video inspections, and 3D digital models of facilities to help clients manage their assets in an affordable manner. HighCandi’s app, which can memorise and automate inspection regimes, makes sure that each drone delivers consistent imaging and data. The company's aerial videographers are Civil Aviation Authority (CAA) licensed and adhere to legal restrictions wherever they film. The company's strategy is to target 10% ($520 million) of two key sectors, namely The Global Industrial Inspection market and European Real Estate market, by 2021. HighCandi is a potential disruptor in the drone sector which is expected to boost the UK economy by £42 billion. With the investment, the company will start recruitment to drive sales, pilot engagement, and brand marketing.
days to go:
Expired
investment:
Withheld
